Locatelli Elyana V T, Huang Jaxon J, Mangwani-Mordani Simran, Tovar Vetencourt Arianna A, Galor Anat
Surgical and Research Services, Miami Veterans Affairs Medical Center, Miami, FL 33125, USA.
Bascom Palmer Eye Institute, University of Miami, Miami, FL 33136, USA.
J Clin Med. 2023 Oct 15;12(20):6535. doi: 10.3390/jcm12206535.
Dry eye disease is an umbrella term that includes a variety of symptoms and signs. A link between diabetes mellitus and dry eye disease exists, but the associated phenotype needs further examination. Thus, our aim was to determine how diabetes mellitus relates to the dry eye disease phenotype. A prospective, cross-sectional study was conducted at the Miami Veteran Affairs Medical Center ophthalmology clinic between October 2013 and September 2019. Participants included a volunteer sample of 366 South Florida veterans with one or more symptoms or signs of dry eye disease [Dry Eye Questionnaire-5 ≥ 6 OR tear break-up time ≤ 5 OR Schirmer's test score ≤ 5 OR corneal fluorescein staining ≥ 2]. Participants were divided into three groups: (1) individuals without diabetes mellitus (controls); (2) individuals with diabetes mellitus but without end-organ complications; and (3) individuals with diabetes mellitus and end-organ complications. Dry eye metrics were compared across groups. The main outcome measures included ocular symptom questionnaires [e.g., 5-item Dry Eye Questionnaire, Ocular Surface Disease Index, and ocular pain assessment] and clinical parameters obtained from an ocular surface evaluation. A total of 366 individuals were included (mean age 59 ± 6 years; 89% males; 39% White; 11% diabetes mellitus and end-organ complications; 15% diabetes mellitus but without end-organ complications). Individuals with diabetes mellitus and end-organ complications had lower symptom scores on the dry eye disease and pain-specific questionnaires compared to individuals with diabetes mellitus but without end-organ complications and controls (Ocular Surface Disease Index: 42.1 ± 24.5 vs. 38.9 ± 25.1 vs. 23.6 ± 16.2; < 0.001; numerical rating scale of ocular pain intensity: 4.9 ± 3.2 vs. 4.3 ± 2.7 vs. 3.5 ± 2.7; = 0.02). Eyelid laxity was also more severe in the group with diabetes mellitus and end-organ complications (0.69 ± 0.64 vs. 0.73 ± 0.72 vs. 1.08 ± 0.77; = 0.004) compared to the two other groups. The diabetic dry eye disease phenotype is driven by signs more so than by symptoms, with anatomic eyelid abnormalities being more frequent in individuals with diabetes mellitus and end-organ complications. Given this, ocular surface abnormalities in individuals with DM may be missed if screened by symptoms alone. As such, individuals with DM should undergo a slit lamp examination for signs of ocular surface disease, including anatomic abnormalities.
干眼疾病是一个涵盖多种症状和体征的统称。糖尿病与干眼疾病之间存在关联,但相关表型需要进一步研究。因此,我们的目的是确定糖尿病与干眼疾病表型之间的关系。2013年10月至2019年9月期间,在迈阿密退伍军人事务医疗中心眼科诊所进行了一项前瞻性横断面研究。参与者包括366名南佛罗里达退伍军人的志愿者样本,他们有干眼疾病的一种或多种症状或体征[干眼问卷-5≥6或泪膜破裂时间≤5或泪液分泌试验评分≤5或角膜荧光素染色≥2]。参与者被分为三组:(1)无糖尿病个体(对照组);(2)患有糖尿病但无终末器官并发症的个体;(3)患有糖尿病且有终末器官并发症的个体。对各组的干眼指标进行比较。主要结局指标包括眼部症状问卷[如5项干眼问卷、眼表疾病指数和眼部疼痛评估]以及从眼表评估中获得的临床参数。共纳入366名个体(平均年龄59±6岁;89%为男性;39%为白人;11%患有糖尿病且有终末器官并发症;15%患有糖尿病但无终末器官并发症)。与患有糖尿病但无终末器官并发症的个体和对照组相比,患有糖尿病且有终末器官并发症的个体在干眼疾病和疼痛特异性问卷上的症状评分更低(眼表疾病指数:42.1±24.5 vs. 38.9±25.1 vs. 23.6±16.2;P<0.001;眼部疼痛强度数字评分量表:4.9±3.2 vs. 4.3±2.7 vs. 3.5±2.7;P = 0.02)。与其他两组相比,患有糖尿病且有终末器官并发症的组眼睑松弛也更严重(0.69±0.64 vs. 0.73±0.72 vs. 1.08±0.77;P = 0.004)。糖尿病干眼疾病表型更多地由体征而非症状驱动,在患有糖尿病且有终末器官并发症的个体中,解剖学眼睑异常更为常见。鉴于此,如果仅通过症状进行筛查,糖尿病患者的眼表异常可能会被漏诊。因此,糖尿病患者应接受裂隙灯检查,以检查眼表疾病的体征,包括解剖学异常。